“Serum β-HCG As an Indicator for Persistence in Gestational Trophoblastic Neoplasia”. The Insight 9, no. 02 (June 18, 2026): 476–482. Accessed July 11, 2026. https://www.bdjournals.org/insight/article/view/1269.